PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China.\', \'Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Disease (CEEID), Chinese Academy of Sciences, 100101, Beijing, China.\', \'NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control and Prevention, China CDC, 102206, Beijing, China.\', \'University of Chinese Academy of Sciences, 100049, Beijing, China.\', \'Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, 201204, Shanghai, China.\', \'Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, 100101, Beijing, China.\', \'Department of Pathogen Microbiology, School of Basic Medical Sciences, Capital Medical University, 100069, Beijing, China.\', \'Savaid Medical School, University of Chinese Academy of Sciences, 100049, Beijing, China.\', \'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China. lixb@im.ac.cn.\', \'University of Chinese Academy of Sciences, 100049, Beijing, China. lixb@im.ac.cn.\', \'NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control and Prevention, China CDC, 102206, Beijing, China. tanwj@ivdc.chinacdc.cn.\', \'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China. jxqi@im.ac.cn.\', \'Savaid Medical School, University of Chinese Academy of Sciences, 100049, Beijing, China. jxqi@im.ac.cn.\', \'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China. gaof@im.ac.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-020-18233-x
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 32887884
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all